|
|
Quick Review for Patients
Note: click on underlined words for more detail or photos.
Another pseudosarcomatous lesion is proliferative myositis, a reactive
fibroproliferative lesion of injured striated muscle. Some authorities consider it to be an early stage of
heterotopic
ossification or myositis ossificans, while others consider
it to be a separate clinical and histopathologic entity. As with nodular
fasciitis, accurate microscopic diagnosis is extremely important. In
some investigations, more than 40% of proliferative myositis cases have been
erroneously diagnosed as sarcoma, especially rhabdomyosarcoma. This reactive lesion is usually seen
in the flat muscles of the shoulder girdle, but occasionally presents in
the head and neck region, particularly in the sternocleidomastoid
muscle. It was first described by Kern in 1960.
Clinical Features Proliferative myositis of the oral region
is a rapidly enlarging, immovable, perhaps tender submucosal mass. Children
are rarely affected and the typical patient is 45-65 years of age at tumor
onset. There is a slight female predilection. The lesion is
usually 1.5-5.0 cm. in greatest dimension at the time of diagnosis and involves
the muscle in a diffuse, infiltrative fashion. Pathology and Differential Diagnosis This lesion appears almost scar-like on gross examination, with a poorly circumscribed periphery and a grayish-white cut surface. Microscopically, plump fibroblast-like cells are the predominant cell type, but giant ganglion-like cells with deeply staining basophilic cytoplasm and prominent nucleoli are the hallmark of proliferative myositis. These cells are also myofibroblasts but are often so bizarre as to impart a strong similarity to rhabdomyosarcoma or other sarcoma. Likewise, atrophic or degenerated muscle cells may contribute to the overall impression of striated muscle malignancy.
Fibrosis is seen to involve the endomysium, perimysium and epimysium. Lesional
cells are immunoreactive for vimentin, actin, smooth-muscle actin, factor
XIIIa, and fibronectin, and are usually not reactive for desmin or
myosin. Occasionally, however, they will also react for desmin
and myosin. Ultrastructurally, they appear to be
myofibroblasts. Focal ossification or dystrophic calcification
may be observed in some cases, but never is it as pronounced as in
heterotopic ossification. Treatment and Prognosis Spontaneous regression and
disappearance has been rarely reported. Treatment of this self-limiting lesion
is conservative surgical excision and recurrence should not be
expected. The major prognostic difficulty is the arrival at
a correct diagnostic interpretation of the tissue, hence, recurrent lesions
should be carefully evaluated for an alternative diagnosis. References (Chronologic Order) Note: General references can be found by clicking on that topic to the left. Ushigome S, Takakuwa T, Takagi M, et al. Proliferative myositis and fasciitis. Report of five cases with an ultrastructural and immunohistochemical study. Acta Pathol Jpn 1986; 36:963. Dent CD, DeBoom GW, Hamlin ML. Proliferative myositis of the head and neck. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 1994; 78:354-358.
Turner R, Robson A, Motley R. Proliferative
myositis - an unusual cause of multiple subcutaneous nodules. Clin Exper
Dermatol 1997; 22:101-103.
Note: To see enlarged photo, click on
the left-hand picture;
| |||||||||||